US Bancorp’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

US Bancorp’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15	Closed	-$915	–	4260
2025 Q1	$915	Hold	15	–	–	﹤0.01%	3996
2024 Q4	$1.35K	Hold	15	–	–	﹤0.01%	3920
2024 Q3	$1.93K	Hold	15	–	–	﹤0.01%	3796
2024 Q2	$1.7K	Hold	15	–	–	﹤0.01%	3741
2024 Q1	$1.99K	Hold	15	–	–	﹤0.01%	3726
2023 Q4	$1.83K	Hold	15	–	–	﹤0.01%	3719
2023 Q3	$1.14K	Hold	15	–	–	﹤0.01%	3748
2023 Q2	$1.78K	Hold	15	–	–	﹤0.01%	3711
2023 Q1	$1.47K	Hold	15	–	–	﹤0.01%	3822
2022 Q4	$2.12K	Hold	15	–	–	﹤0.01%	3757
2022 Q3	$2K	Hold	15	–	–	﹤0.01%	3837
2022 Q2	$2K	Sell	15 -55	-79%	-$9.37K	﹤0.01%	3846
2022 Q1	$22K	Buy	70 +55	+367%	+$20.7K	﹤0.01%	3026
2021 Q4	$11K	Buy	+15	New	+$14.4K	﹤0.01%	3386

Other funds holding LABU

Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EFG

Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

US Bancorp's LABU Position: Q2 2025 in Review

US Bancorp sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2025, closing a stake of 15 shares — an estimated $915 sold.

US Bancorp first reported a position in LABU in Q4 2021 and held it in 14 quarters. The position peaked at $22K in Q1 2022. 34 funds tracked by Wall St. Rank hold LABU as of Q2 2025.

US Bancorp reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
US Bancorp sold 15 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2025, an estimated $915.
US Bancorp first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2021 and held it in 14 quarters.
US Bancorp's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $22K in Q1 2022.
34 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2025.

Based on US Bancorp's 13F filing for Q2 2025, filed 24 Jul 2025.